279
Participants
Start Date
May 22, 2020
Primary Completion Date
November 24, 2022
Study Completion Date
November 24, 2022
PRESERFLO® MicroShunt
Device surgically implanted
Trabeculectomy
The procedure involves removal of a small portion of the trabecular meshwork and adjacent scleral tissue. Aqueous humor then drains into the subconjunctival space, creating a bleb on the external part of the eye, where it diffuses away.
New York Eye and Ear Infirmary of Mt. Sinai, New York
Glaucoma Consultants of the Capital Region, Slingerlands
Ophthalmic Partners of Pennsylvania, Bala-Cynwyd
Hospital Clínico San Carlos, Madrid
Pôle Ophtalmologique de la Clinique Mutualiste, Pessac
Ophthalmic Surgeons and Consultants of Ohio, Columbus
Cincinnati Eye Institute, Cincinnati
Eugene and Marilyn Glick Eye Institute, Indianapolis
Minnesota Eye Consultants, PA, Bloomington
A. O.U.P (Azienda Ospedaliere Universitaria Pisana) Stabilimento di Cisanello, Pisa
Stiles Eye Care Excellence & Glaucoma Institute, Overland Park
Vold Vision, Fayetteville
Dean McGee Eye Institute, Oklahoma City
Glaucoma Associates of Texas, Dallas
Ophthalmology Associates, Fort Worth
University Eye Associates, Houston
R&R Eye Research, LLC, San Antonio
Intermountain Eye Center, Eagle
Arizona Advance Eye Research Institute, LLC., Glendale
UCLA Medical Center Jules Stein Eye Institute, Los Angeles
University of California at Davis Eye Center, Sacramento
Ophthalmic Consultants of Connecticut, Meriden
Moorfields Eye Hospital, London
Lead Sponsor
InnFocus Inc.
INDUSTRY